Japanese digital health company developing software as a medical device (SaMD) and digital therapeutics (DTx), including smartphone-based treatments for migraine and premenstrual syndrome
Japanese digital health company developing software as a medical device (SaMD) and digital therapeutics (DTx), including smartphone-based treatments for migraine and premenstrual syndrome. Its migraine app uses behavioral pattern recognition and cognitive behavioral therapy to connect everyday life with medical care.
The top three firms on F4's Healthcare & Digital Health investor list.